AlTi Global’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
AlTi Global's VRTX Position: Q2 2026 in Review
AlTi Global increased its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q2 2026, buying an estimated $19.1K and bringing the position to 716 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #407.
AlTi Global first reported a position in VRTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $380K in Q1 2024. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- AlTi Global held 716 shares of Vertex Pharmaceuticals worth $356K as of Q2 2026.
- AlTi Global bought 43 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.1K.
- Vertex Pharmaceuticals made up 0.01% of AlTi Global's portfolio in Q2 2026, its #407 holding.
- AlTi Global first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
- AlTi Global's Vertex Pharmaceuticals position peaked at $380K in Q1 2024.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.